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Abstract
In neurodegenerative disorders, such as Parkinson’s disease (PD), alpha-synuclein (α-syn)
accumulates to induce cell death and/or form a cytoplasmic inclusion called Lewy body
(LB). This α-syn-related pathology is termed synucleinopathy. It remains unclear how α-syn
accumulation expands during the progress of synucleinopathy in the human brain. In our
study, we investigated the patterns of distribution and propagation of forebrain neurons
expressing α-syn in aged macaques. It was found that the occurrence of α-syn-positive neu-
rons proceeded topologically based on the midbrain dopamine pathways arising from the
substantia nigra and the ventral tegmental area where they were primarily observed. In the
nigrostriatal or mesolimbic dopamine pathway, the age-dependent increase in α-syn-posi-
tive neurons was evident in the striatum or the nucleus accumbens, respectively. Concern-
ing the nigrostriatal pathway, a mediolateral or rostrocaudal gradient was seen in the
substantia nigra or the striatum, respectively, and a compensatory increase in dopamine
transporter occurred in the striatum regardless of the decreased dopamine level. In the
mesocortical dopamine pathway, α-syn-positive neurons appeared in the prefrontal and
then motor areas of the frontal lobe. Given that neither LB formation nor clinical phenotype
manifestation was detected in any of the monkeys examined in the present study, aged
macaques may be useful as a potential presymptomatic model for PD and LB-related neuro-
psychiatric disorders.
Introduction
Alpha-synuclein (α-syn) is a 140-amino acid protein that is localized specifically to the presyn-
aptic terminals and nuclei of neuronal cells, though its physiological functions remain to be
known [1,2]. In at least part of neurodegenerative disorders, the onset of cell death is charac-
terized by unusual accumulation of α-syn within the cytoplasm. This α-syn-related pathologi-
cal condition is generally termed synucleinopathy [3]. The most representative disorder in
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synucleinopathy is Parkinson’s disease (PD) that is caused by degeneration of dopaminergic
neurons in the substantia nigra, resulting in motor impairments due to dysfunction of the
nigrostriatal dopamine system [4]. In PD, dopaminergic neuron degeneration is triggered by
excess accumulation of phosphorylated α-syn, which leads to the formation of a cytoplasmic
inclusion, so-called Lewy body (LB) [5,6]. Thus, LB is a major pathological hallmark character-
istic of PD. The α-syn pathology was first defined in familial types of PD [7,8]. For example,
type 1 familial PD (PARK1) is ascribed to mutation of the SNCA gene that encodes α-syn [9].
The SNCA gene abnormality results in overexpression and drastic aggregation of α-syn. A
similar mechanism underlies type 4 familial PD (PARK4) in which the SNCA gene is triplet
and α-syn production is more rapid than in PARK1 [10,11]. It is well known that the α-syn
pathology is involved not only in familial types, but also in sporadic cases of PD [12].
Clinical reports have shown that dementia is developed or accompanied in many of PD
patients to induce Parkinson’s disease with dementia (PDD) or dementia with Lewy bodies
(DLB), respectively [13,14]. Like PD, the α-syn pathology provides a conspicuous sign for
these types of dementia [15]. Together with PD, PDD and DLB are classified as Lewy body dis-
eases, and LB is found not only in the substantia nigra, but also extensively in cortical and sub-
cortical regions [16]. Furthermore, PD has various non-motor symptoms, such as psychiatric
disorders, gastrointestinal problems, and autonomic failures. These non-motor symptoms
appear 10–30 years prior to the onset of motor symptoms. Such a “presymptomatic” state is
not fully investigated and is sometimes called incidental LB disease [12].
To understand the pathophysiology of synucleinopathy, it is important to know how α-syn
accumulation expands in the process of normal aging. However, the following problems make
it very difficult to analyze this issue using human brains. First, the human brain is too huge to
undergo pathological examinations throughout the brain. Second, it is quite painful to collect
brain samples at individual ages with no history of neuropsychiatric disorders. Instead of
human brains, the application of nonhuman primate brains is meritorious for exploring the
extent of α-syn accumulation during normal aging. In fact, Chu et al. [17] performed counts of
α-syn-positive neurons in the substantia nigra in aged human and monkey brains, and
obtained the data showing that the number of α-syn-positive nigral neurons is increased at a
similar rate in both of the aged brains. Recently, several studies suggest that the α-syn pathol-
ogy is transmitted from neuron to neuron in relation to disease development [18–23]. In PD
and related disorders, the neuron-to-neuron transmission is most likely to depend on the mid-
brain dopamine systems, including the nigrostriatal pathway.
In the present study, we investigated the patterns of distribution and propagation of α-syn-
positive neurons in aged monkey brains, in order to elucidate when and where synucleinopa-
thy starts and how synucleinopathy develops. Particular attention was paid to forebrain struc-
tures, including the frontal cortical areas. In addition, closer analysis was carried out to clarify
the age-dependent progress in the α-syn pathology of the nigrostriatal dopamine system. For
this work, we used a total of 14 macaque monkeys without abnormal movement sign or past
disease history. Their ages ranged 10–31 years old. According to previous reports [24,25], the
age of macaques is approximately three times as much as that of humans. Thus, the ages of the
monkeys used here are equivalent to 30–93 years old in humans.
Materials and Methods
The experimental protocol used for this study including animal sacrifice was approved by the
Animal Welfare and Animal Care Committee of the Primate Research Institute, Kyoto Univer-
sity (Permission Number: 2013–008). All experiments were conducted in accordance with the
Guidelines for Care and Use of Nonhuman Primates (Ver. 3, 2010) issued by the institute.
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Animals
Fourteen macaque monkeys [seven Japanese monkeys (Macaca fuscata), six cynomolgus mon-
keys (Macaca fascicularis), and one rhesus monkey (Macaca mulatta)] of either sex weighing
4.0–8.5 kg were used for this study. As described in Table 1, the ages of these monkeys were
between 10 and 31 years old, corresponding to 30–93 years old in humans [24,25]. All mon-
keys were supplied from colonies in the Primate Research Institute. The monkeys were origi-
nally housed in group cages, and a few days before sacrifice, they were moved to individual
cages (780 mm wide x 790 mm deep x 870 mm high; wooded toys provided as environmental
enrichment) for precise behavioral inspection. The individual cages were administered on a
12-h on/12-h off lighting schedule and had ad libitum access to food and water. Each of the
monkeys had his/her own health record with the birth date; there was no history of either dis-
ease or medication. At the time of sacrifice, none of them exhibited any discernible signs of
motor impairments.
Immunohistochemical procedures
Following sedation with ketamine hydrochloride (10 mg/kg, i.m.) and xylazine hydrochloride
(1–2 mg/kg, i.m.), the monkeys were deeply anesthetized with an overdose of sodium pento-
barbital (50 mg/kg, i.v.) for perfusion-fixation. The monkeys were transcardially perfused with
0.1 M phosphate-buffered saline (PBS; pH 7.4), followed by 10% formalin in 0.1 M phosphate
buffer (PB; pH 7.4). The brains were removed from the skull, postfixed in the same fresh fixa-
tive overnight, and saturated with 30% sucrose in PB at 4˚C. Frontal sections were then cut
serially at 50 μm thickness on a freezing microtome and processed for immunohistochemical
staining with the avidin-biotin peroxidase complex (ABC) method. A series of every ten sec-
tions were immunostained for α-syn, phosphorylated α-syn, tyrosine hydroxylase (TH), or
dopamine transporter (DAT). Especially for TH and DAT immunostaining, the sections
through the striatum and the substantia nigra were used. After washes in PBS, the sections
were soaked in 0.3% H2O2 for 30 min to inactivate endogenous peroxidase and immersed in
1% skim milk for 1 h at room temperature. For single bright-field staining, they were incu-
bated at 4˚C with mouse monoclonal antibody against α-syn (BD Biosciences, San Jose, CA,
Table 1. List of macaques used. Cynomolgus, cynomolgus monkey (Macaca fascicularis); F, female; Japa-
nese, Japanese monkey (Macaca fuscata); M, male; m, months; Rhesus, rhesus monkey (Macaca mulatta);
y, years.
Name Spieces Age Gender
IB Cynomolgus 10y0m F
WS Japanese 14y3m F
KL Japanese 19y1m F
SK Cynomolgus 20y6m F
OM Cynomolgus 21y10m M
RJ Japanese 22y0m F
HU Cynomolgus 23y2m M
AY Cynomolgus 24y0m F
DD Japanese 25y11m F
GF Cynomolgus 26y7m M
QR Japanese 27y0m F
TK Japanese 29y4m F
EK Rhesus 30y4m F
DL Japanese 31y7m F
doi:10.1371/journal.pone.0166861.t001
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USA) at a 1:2,000 dilution, mouse monoclonal antibody against phosphorylated α-syn (Wako,
Tokyo, Japan) at a 1:5,000 dilution, rabbit polyclonal antibody against TH (Millipore, Billerica,
MA, USA) at a 1:1,000 dilution, or rat monoclonal antibody against DAT (Millipore) at a
1:1,000 dilution, in PBS containing 0.1% Triton X-100 and 2% normal donkey serum. After 48
h, the sections were washed in PBS and incubated in the same fresh medium containing bioti-
nylated goat anti-mouse/anti-rabbit/anti-rat IgG antibody (Vector Laboratories, Burlingame,
CA, USA; diluted at 1:200) for 2 h at room temperature, followed by avidin-biotin-peroxidase
complex (ABC Elite, Vector Laboratories) for 2 h at room temperature. Subsequently, the sec-
tions were reacted in in 0.05 M Tris-HCl buffer (pH 7.6) containing 0.04% diaminobenzidine
tetrahydrochloride (Merck, Darmstadt, Germany), 0.04% NiCl2, and 0.002% H2O2. Finally,
the sections were mounted onto gelatin-coated glass slides, air-dried, counterstained with 1%
Neutral red, and coverslipped. Another series of sections was Nissl-stained with 1% Cresyl
violet.
For double immunofluorescence staining for α-syn and TH or TH and NeuN, the sections
through the substantia nigra were incubated with a cocktail of the mouse anti-α-syn antibody
(BD Biosciences; diluted at 1:1,000) and the rabbit anti-TH antibody (Millipore; diluted at
1:1,000), or a cocktail of the rabbit anti-TH antibody (Millipore; diluted at 1:1,000) and mouse
monoclonal antibody against NeuN (Millipore; diluted at 1:2,000). The sections were then
incubated with a cocktail of Alexa Fluor 555-conjugated donkey anti-mouse IgG antibody
(Molecular Probes, Eugene, OR, USA; diluted at 1:300) and Alexa Fluor 488-conjugated don-
key anti-rabbit IgG antibody (Molecular Probes; diluted at 1:200). Images of sections were dig-
itally captured at x4 or x10 magnification using an optical microscope equipped with a high-
grade charge-coupled device (CCD) camera (Biorevo, Keyence, Osaka, Japan).
Quantitative analyses
Anatomical structures were identified by referring to “A Combined MRI and Histology Atlas
of the Rhesus Monkey Brain in Stereotaxic Coordinates” [26] and “The Rhesus Monkey Brain
in Stereotaxic Coordinates” [27].
In individual monkeys, the numbers of α-syn-positive and TH-positive neurons were
counted in the ventral midbrain, including the substantia nigra pars compacta (SNc) and the
ventral tegmental area (VTA). Cell counts were performed in every ten sections 50 μm thick (a
total of 8–10 sections per monkey) on each side, and the data obtained were averaged and
expressed as the number in the area of 1 mm2. The entire process was done on digitally cap-
tured x40 images by the aid of Adobe Photoshop CS5 software and Adobe Illustrator CS5 soft-
ware. When the numbers of α-syn-positive and TH-positive neurons were compared in the
medial vs. lateral parts of the SNc, 3 regions of interest (ROIs) each of which was 200 μm x
200 μm were placed in both parts along the mediolateral axis. In each part, the cell counts
obtained in the ROIs were averaged and converted into the number in the area of 1 mm2. The
same process as described above was taken for analysis.
The number of α-syn-positive neurons was also counted in forebrain structures, including
the frontal cortical areas. In each structure, cell counts were performed in every ten sections
50 μm thick (a total of 2–6 sections per monkey) on each side. On each section, 3 ROIs of
200 μm x 200 μm were placed. The data obtained in the ROIs were averaged, and then the neu-
ron number per section was calculated.
For double immunofluorescence staining for α-syn and TH or TH and NeuN, cell counts
were carried out in 3 ROIs of 200 μm x 200 μm that were placed within nigral zones where
clusters of TH-positive neurons were located in every ten sections (a total of 8–10 sections per
monkey).
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In individual monkeys, the density of TH immunoreactivity or DAT immunoreactivity was
measured in the striatum. Measurements of optical density (OD) were performed in 2 ROIs of
500 μm x 500 μm placed in each of the caudate nucleus and the putamen in every ten sections
(a total of 12–16 sections per monkey) on each side. The OD was measured by the aid of
Adobe Photoshop CS5 software and Adobe Illustrator CS5 software, and the value obtained in
the ROIs in each section was averaged and expressed as a ratio to a control value (OD taken
from the anterior limb of the internal capsule). The entire process was done on digitally cap-
tured x40 images by the aid of Adobe Photoshop CS5 software. Finally, the mean OD ratio per
section was calculated. When the OD ratio was compared in the rostral vs. caudal levels of the
striatum, the boundary was set at the level of the anterior commissure.
The cell counts and OD ratios were analyzed by Mann-Whitney test. Correlations between
the cell counts and the age, or those between the OD ratios and the age were examined. Signifi-
cance for each analysis was set a priori at 0.05. All the statistical analyses were done by the aid
of IBM SPSS Statistics 22 package and Microsoft Excel 2010.
Results
As listed in Table 1, 14 macaque monkeys (seven Japanese monkeys, six cynomolgus monkeys,
and one rhesus monkey) ranging 10–31 years old were used for the present analyses. These
monkeys had no history of diseases or medications. All the monkeys were basically in healthy
conditions, and virtually no motor abnormalities were observed in any individuals.
Age-dependent changes in the distribution of α-syn-positive neurons in
the nigrostriatal dopamine system
In the youngest 10-year-old monkey, α-syn-positive neurons were found prominently in the
SNc (Table 2). Therefore, we first analyzed the age-dependent changes in the distribution of α-
syn-positive neurons in the nigrostriatal dopamine system. At 10 years of age, a number of α-
syn-positive neurons were already located in the SNc, though α-syn immunoreactivity in each
neuron was not so intense as compared to that at older ages. As the age went, α-syn-positive
neurons in the SNc gradually increased in both number and intensity (Figs 1A and 2). By 30
Table 2. Distribution patterns of α-syn-positive neurons in subcortical structures. -, none; +, sparse (1-10/ROI); ++, moderate (11-20/ROI); +++,
dense (21-/ROI). Amy, amygdala; Hip, hippocampus; LS, lateral septum; m, months; NA, nucleus accumbens; RRF, retrorubral field; SNc, substantia nigra
pars compacta; Str, striatum; VTA, ventral tegmental area; y, years.
Name Age SNc VTA RRF Str NA LS Amy Hip
IB 10y0m ++ + + - - - + +
WS 14y3m ++ + + - - - + ++
KL 19y1m ++ + + - - - + ++
SK 20y6m +++ + + + - - + ++
OM 21y10m +++ ++ + - + - + ++
RJ 22y0m +++ ++ + + - - + ++
HU 23y2m +++ ++ ++ + + - + ++
AY 24y0m +++ ++ + + + + + ++
DD 25y11m +++ ++ ++ + + + + +++
GF 26y7m +++ ++ + + + + ++ +++
QR 27y0m +++ ++ ++ ++ + + ++ +++
TK 29y4m +++ ++ + ++ + + +++ +++
EK 30y4m +++ +++ ++ ++ ++ + ++ +++
DL 31y7m +++ +++ ++ ++ ++ + +++ +++
doi:10.1371/journal.pone.0166861.t002
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years of age, the number of α-syn-positive neurons was increased about five times as many as
that at 10 years of age (Fig 1B). Conversely, the number of TH-immunoreactive neurons in the
SNc was decreased by more than 50% with the age (Fig 1A and 1B). Double immunofluores-
cence histochemistry confirmed that substantially all α-syn-positive neurons were immunore-
active for TH throughout all the ages examined (Fig 2). These overall results suggest that nigral
dopamine neurons in aged macaque brains come to express α-syn frequently, and that at least
some of them degenerate to death. Around 30 years of age, the number of α-syn-positive neu-
rons became close to that of TH-immunoreactive neurons, indicating that most of the surviv-
ing nigral dopamine neurons express α-syn definitively. We further examined the possible
difference in α-syn-positive neuron distribution in the mediolateral direction of the SNc. At
Fig 1. Age-dependent distribution changes in α-syn-positive and TH-positive neurons in the SNc. A: Number of α-syn-positive or
TH-positive neurons in the area of 1 mm2. The red or black line with filled squares represents the α-syn-positive or TH-positive neuron
number, respectively. B: Ratio of the α-syn-positive (specified by the red line with filled squares) or TH-positive (specified by the black line
with filled squares) neuron number to each number at 10 years of age. C: Number of α-syn-positive neurons in the medial or lateral part of
the SNc. The neuron number is indicated as that in the area of 1 mm2. The solid line with filled circles or broken line with open circles
represents the neuron number in the medial or lateral part, respectively. D: Number of TH-positive neurons in the medial (denoted by the
solid line with filled circles) or lateral (denoted by the broken line with open circles) part of the SNc. The neuron number is indicated as that in
the area of 1 mm2. See the text for methodological details.
doi:10.1371/journal.pone.0166861.g001
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younger ages, α-syn-positive neurons were distributed more frequently in the lateral than in
the medial part of the SNc (p = 0.0362, Figs 1C, 3A and 3B). The α-syn-positive neuron num-
bers in the medial vs lateral parts became close or almost the same or even reversed at older
ages than 25 years (Fig 1C). By contrast, more TH-immunoreactive neurons were located in
the medial than in the lateral part of the SNc at substantially all ages (p = 0.0278, Figs 1D, 3C
and 3D). In none of the monkeys used here, abnormal inclusions reminiscent of LB were
detected in nigral dopamine neurons.
The density of TH-immunoreactive fibers and terminals in the striatum was gradually
reduced as the age went (Fig 4A for the caudate nucleus and Fig 4B for the putamen).
Throughout all the ages tested, TH immunoreactivity was seen less intensely in the caudal than
in the rostral aspect of the striatum (caudate; p = 0.0276, putamen; p = 0.0045, Figs 3E, 3F, 4A
and 4B). Moreover, comparison between the caudate nucleus and the putamen revealed that
TH immunoreactivity was less densely observed in the putamen than in the caudate nucleus
regardless of the age (p = 0.0354, Fig 4C). When DAT immunoreactivity that was localized at
the presynaptic terminals was also examined in the striatum, it was found that unlike the TH-
immunoreactive terminal density, the density of DAT-immunoreactive terminals was not
essentially reduced even in the far-aged brains (Fig 5A and 5B). Moreover, double immunoflu-
orescence histochemistry for TH and NeuN confirmed that the vast majority of NeuN-positive
neurons in the SNc displayed TH immunoreactivity throughout all the ages examined (Fig
5C). This implies that even at older ages, most of the surviving neurons in the SNc are dopami-
nergic (i.e., they retain the capability of dopamine synthesis), because they still express TH.
Although α-syn-positive fibers and terminals in the striatum seemed incremental with the
age, their density could not to be analyzed quantitatively in an exact manner. More interest-
ingly, α-syn-positive neurons appeared in the striatum at older ages than 20 years and gradu-
ally increased in number (Table 2).
Fig 2. Photomicrographs of double immunofluorescence staining for α-syn and TH in SNc at 10 (A,A’,
A”) and 31 (B,B’,B”) years of age. Note that the intensity of α-syn is weak in many TH-positive neurons at 10
years of age, and that the vast majority of TH-positive neurons are clearly immunostained for α-syn at 31
years of age. Scale bars, 50 μm.
doi:10.1371/journal.pone.0166861.g002
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Fig 3. Photomicrographs of α-syn and TH immunostaining in the nigrostriatal dopamine system and
forebrain structures at 31 years of age. A: α-Syn-positive neurons in the medial part of the SNc (mSNc). B:
α-Syn-positive neurons in the lateral part of the SNc (lSNc). C: TH-positive neurons in the mSNc. D: TH-
positive neurons in the lSNc. E: TH-positive fibers and terminals in the rostral aspect of the putamen (rPut). F:
TH-positive fibers and terminals in the caudal aspect of the putamen (cPut). G: Phosphorylated α-Syn
immunostaining in the lSNc. G: Phosphorylated α-Syn immunostaining in the amygdala (Amy). Scale bars,
50 μm.
doi:10.1371/journal.pone.0166861.g003
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Fig 4. Age-dependent density changes in TH immunoreactivity in the striatum. A: Change in TH
immunoreactivity in the caudate nucleus at the rostral or caudal level. The density ratio was measured in
comparison with background staining in the internal capsule as a control. The solid line with filled circles or
broken line with open circles represents the density ratio at the rostral or caudal level, respectively. B: Change
in TH immunoreactivity in the putamen at the rostral (denoted by the solid line with filled circles) or caudal
α-Syn Pathology in Aged Monkey Brain
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Distribution and propagation of α-syn-positive neurons in subcortical
structures
In monkeys younger than 20 years old, α-syn-positive neurons were located not only in the
SNc, but also in the VTA, the retrorubral field, the amygdala, and the hippocampus (Table 2).
As the age went, the numbers of α-syn-positive neurons in these subcortical structures were
gradually increased, and reached a similar extent to that in the SNc between 25 and 30 years of
age (Table 2). As described above, a number of α-syn-positive neurons were observed in the
striatum at older ages than 20 years (Table 2), and, in addition, α-syn-positive neurons
emerged in the nucleus accumbens and the lateral septum by 25 years of age (Table 2). Espe-
cially in the striatum and the nucleus accumbens, the numbers of α-syn-positive neurons were
kept increased constantly until over 30 years of age (Table 2). The distribution of α-syn-posi-
tive neurons within the striatum exhibited a rostrocaudal gradient; they were located more fre-
quently in the caudal than in the rostral aspect of the striatum. This topological pattern was
seen more prominently at older ages (data not shown). Throughout all the ages tested, unusual
inclusions like LB were not found in any subcortical structures.
Distribution and propagation of α-syn-positive neurons in frontal cortical
areas
Throughout all the ages examined, both the anterior cingulate cortex and the orbitofrontal
cortex contained α-syn-positive neurons (Table 3; Fig 6A). The numbers of α-syn-positive
neurons in these frontal cortical areas were markedly increased with the age (Table 3). Fur-
thermore, around 20 years of age, α-syn-positive neurons were located in the prefrontal cor-
tex, especially in the dorsolateral prefrontal cortex, and in area 6 of the motor cortex (i.e., the
premotor cortex and the supplementary motor area) (Table 3; Fig 6A and 6B). The numbers
of α-syn-positive neurons in these areas were gradually increased as the age went (Table 3). At
much older ages, α-syn-positive neurons appeared in other areas of the prefrontal cortex, such
as the ventrolateral and medial prefrontal cortices, and in area 4 of the motor cortex (i.e., the
primary motor cortex) (Table 3; Fig 6A and 6C). In none of the monkeys used here, abnormal
inclusions like LB were seen in any frontal cortical areas.
Occurrence of phosphorylated α-syn neurons
Using three representative monkeys at the ages of 20–30 years (monkeys SK, DD, and EK), we
examined whether or not phosphorylated α-syn-positive neurons occur in the aged brain. In
all of these monkeys, only a few faintly-immunostained neurons were observed in the SNc and
the amygdala (Fig 3G and 3H). No other structures contained very few, if any, phosphorylated
α-syn-positive neurons.
Discussion
In present study, we analyzed the patterns of distribution and propagation of forebrain neu-
rons expressing α-syn in aged macaques. The main findings were as follows: (1) α-Syn-positive
neurons appeared topologically along the midbrain dopamine pathways originating in the sub-
stantia nigra and the ventral tegmental area where they were primarily located. (2) Regarding
the nigrostriatal or mesolimbic dopamine pathway, α-syn-positive neurons were increasingly
(denoted by the broken line with open circles) level. C: Change in TH immunoreactivity in the caudate nucleus
(specified by the solid line with filled circles) or the putamen (specified by the broken line with open circles).
See the text for methodological details.
doi:10.1371/journal.pone.0166861.g004
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Fig 5. Age-dependent changes in striatal DAT immunoreactivity and nigral TH-positive neurons. A:
Age-dependent change in DAT immunoreactivity in the striatum. The density ratio was measured in
comparison with background staining in the internal capsule as a control. B: Photomicrographs of DAT
immunostaining in the striatum at 10 (a) and 31 (b) years (yrs) of age. Scale bars, 50 μm. C: Age-dependent
change in the ratio of TH-positive neurons to NeuN-positive neurons in the SNc. Data are obtained from
double immunofluorescence staining for TH and NeuN. See the text for methodological details.
doi:10.1371/journal.pone.0166861.g005
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observed in the striatum or the nucleus accumbens, respectively, in an age-dependent fashion.
(3) In the nigrostriatal pathway, a mediolateral or rostrocaudal gradient was seen in the sub-
stantia nigra or the striatum, respectively. (4) Concerning the mesocortical dopamine pathway,
α-syn-positive neurons were found in the prefrontal and then motor areas of the frontal lobe.
It is generally accepted that in neuropathological conditions, phosphorylated α-syn abnor-
mally accumulates within the cytoplasm and aggregates to form insoluble fibrils characterized
by the intracellular inclusion LB [5]. This α-syn-related event termed synucleinopathy is
widely involved not only in PD, PDD, and DLB, but also in multiple system atrophy and part
of Alzheimer’s disease (AD) [7,8,28,29]. In order to understand the progress in synucleinopa-
thy, it is essential to study how α-syn-positive neurons propagate during normal aging by
using nonhuman primates. A previous report showed that α-syn-positive neurons were found
in the substantia nigra, the striatum, and the cerebral cortex in the aged lemur primate brain
[30]. However, it still remains unknown exactly how the α-syn pathology develops. To eluci-
date when and where synucleinopathy begins and how synucleinopathy proceeds, we explored
the patterns of distribution and propagation of α-syn-positive neurons in aged monkey brains.
In the present study, 14 macaques (seven Japanese monkeys, six cynomolgus monkeys, and
one rhesus monkey) ranging 10–31 years old were used. Based on the fact that the age of
macaques is about three times as much as that of humans [24,25], the ages of these monkeys
correspond to 30–93 years old in humans. All data obtained in individual monkeys were dealt
with together across the species, because there was no marked species difference in the age-
dependent progress in the α-syn pathology.
According to the hypothesis proposed by Braak [31], in PD patients, LB formation first
occurs in the brainstem and the olfactory bulb, and gradually spreads to the midbrain, the
basal ganglia, and the cerebral cortex. This process of extension of LB formation may not nec-
essarily be disease-specific, but may commonly be seen during normal aging as well. Here we
investigated the distribution of α-syn-positive neurons in the forebrain, including cortical and
subcortical regions, of aged macaques. As previously reported [17], the number of α-syn-posi-
tive neurons in the SNc is increased with the age. Conversely, the number of dopaminergic
(TH-positive) neurons is decreased in the SNc. The older the age becomes, the more frequently
Table 3. Distribution patterns of α-syn-positive neurons in frontal cortical areas. -, none; +, sparse (1-10/ROI); ++, moderate (11-20/ROI); +++, dense
(21-/ROI). ACC, auterior cingulate cortex; Area 4, area 4 of the motor cortex; Area 6, area 6 of the motor cortex; DLPF, dorsolateral prefrontal cortex; MPF,
medial prefrontal cortex; m, months; OF, orbitofrontal cortex; VLPF, ventrolateral prefrontal cortex; y, years.
Name Age ACC OF DLPF VLPF MPF Area 6 Area 4
IB 10y0m + + - - - - -
WS 14y3m + + - - - - -
KL 19y1m + + + - - + -
SK 20y6m + + - - - - -
OM 21y10m ++ ++ + - - + -
RJ 22y0m ++ ++ - - - + -
HU 23y2m ++ ++ + + + + -
AY 24y0m ++ ++ + + - + +
DD 25y11m ++ ++ + - - + -
GF 26y7m +++ +++ ++ + + + -
QR 27y0m ++ +++ ++ + - + -
TK 29y4m +++ +++ ++ + + + +
EK 30y4m +++ +++ ++ + + + +
DL 31y7m +++ +++ ++ + + ++ +
doi:10.1371/journal.pone.0166861.t003
α-Syn Pathology in Aged Monkey Brain
PLOS ONE | DOI:10.1371/journal.pone.0166861 November 18, 2016 12 / 18
nigral dopamine neurons express α-syn. By 30 years of age, the α-syn-positive neurons reach
five times more than those at 10 years of age, and, finally, most of the remaining nigral dopa-
mine neurons express α-syn. It is known that familial PD, i.e., PARK1 and PARK4, is charac-
terized by rapid α-syn accumulation and early disease onset [32]. On the other hand, the
disease onset is usually seen late (at older ages) in most cases of sporadic PD in which as many
as 60–80% of nigral dopamine neurons are damaged when motor symptoms occur [33–36]. In
this context, it is quite reasonable that none of the monkeys used in the present study exhibited
definite signs for PD, because nearly 50% of nigral dopamine neurons are still retained even in
the far-aged monkeys. This implies that the brains in these monkeys may be in presymptom-
atic conditions of PD. In addition, it should also be emphasized here that substantially no
phosphorylated α-syn-positive neurons appeared in any aged monkey brain.
It has been shown that there is topological arrangement in the nigrostriatal dopamine path-
way [37–39]. Neurons in the medial part of the SNc project predominantly to the rostral aspect
of the striatum (especially to the caudate nucleus and the rostral putamen; striatal associative
territory), while those in the lateral counterpart project mainly to the caudal aspect of the
Fig 6. Schematic drawings of the approximate locations of the frontal cortical areas for analyzing the
density of α-syn-positive neurons. Three representative frontal sections are arranged rostrocaudally in
A-C. The rostrocaudal levels of the sections are indicated at the top-right corner. Modified from “The Rhesus
Monkey Brain in Stereotaxic Coordinates” [27]. ACC, anterior cingulate cortex; CgS, cingulate sulcus; CS,
central sulcus; DLPF, dorsolateral prefrontal cortex; iAS, inferior limb of the arcuate sulcus; MPF, medial
prefrontal cortex; OF, orbitofrontal cortex; PS, principal sulcus; sAS, superior limb of the arcuate sulcus;
VLPF, ventrolateral prefrontal cortex.
doi:10.1371/journal.pone.0166861.g006
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striatum (especially to the caudal putamen; striatal motor territory). Recent emphasis has been
placed on the functional heterogeneity as to reward-related response; the former neurons
encode motivational values, and the latter neurons encode motivational salience [40]. The
present results have demonstrated that throughout all ages, the dopaminergic neurons in the
lateral SNc are affected more severely than those in the medial SNc. In favor of these findings,
it has been reported in human PD cases that the pathological change in the SNc is the most
prominently observed in the ventrolateral tier [41–44]. The age-related distribution pattern of
α-syn-positive neurons in the SNc is reversed. The α-syn-positive neurons are located more
numerously in the lateral SNc than in the medial SNc, especially at the earlier stage of aging. In
accordance with the topological organization of the nigrostriatal dopamine pathway, loss of
dopaminergic fibers and terminals from the striatum occurs more markedly at its caudal level
(particularly in the caudal putamen) receiving input from the lateral SNc, than at its rostral
level receiving input from the medial SNc. A previous work [44] has described that the density
of dopaminergic fibers and terminals is reduced in the putamen by 35–75% one-to-three years
after motor symptoms appeared in human PD cases. Although the actual extent of decreased
striatal TH immunoreactivity was not necessarily measured in our study, an insufficient reduc-
tion of striatal dopamine for developing parkinsonian signs is most likely in the aged monkeys
examined here, thus suggesting that they may provide a presymptomatic model for PD.
Contrary to the decreased density of TH immunoreactivity, DAT immunoreactivity in the
striatum remains unchanged even in the far-aged brains. Striatal DAT is localized at the pre-
synaptic terminals of nigral dopamine neurons to promote reuptake of dopamine that is
released from the terminals [45]. This clearly indicates that the striatal DAT immunoreactivity
represents the dopaminergic axon terminals. To explain a serious discrepancy between the
density of TH and DAT immunoreactivity, it is likely to consider that DAT may at least in part
be placed at terminal sites of damaged or degenerating nigrostriatal neurons that can no longer
synthesize dopamine. However, our double immunofluorescence histochemistry for TH and
NeuN has revealed that even at older ages, the surviving neurons in the SNc apparently express
dopamine and thus do not lose the capability of dopamine synthesis. The discrepancy could be
accounted for by postulating that DAT expressed in the remaining dopamine neurons might
display hypersensitivity to maintain intracellular dopamine concentrations. In favor of this
notion, previous works have reported that DAT binding in the striatum is increased in a com-
pensatory manner at early stages of PD onset in MPTP-treated monkeys [46,47].
It has recently been revealed that the α-syn pathology related to disease development is
transmitted based on the neural linkage [18–23]. The present study defines that α-syn-positive
neurons propagate topologically in accordance with the midbrain dopamine systems, as evi-
denced by the findings that α-syn-positive neurons appear in the striatum in an age-dependent
fashion based on dopaminergic input loss along the nigrostriatal pathway responsible for PD.
The α-syn-positive neurons in the striatum occur later than in the SNc and are located in a
topological manner in which they are seen more markedly in the caudal than in the rostral
aspect. This rostrocaudal gradient of α-syn-positive neuron distribution within the striatum
corresponds well with the topological pattern of loss of dopaminergic fibers and terminals
therefrom.
Our results have further demonstrated that the number of α-syn-positive neurons is
increased in the VTA as the age goes, though they appear less rapidly and drastically than in
the SNc. In conjunction with the medial SNc, the VTA gives rise to the mesolimbic and meso-
cortical dopamine pathways [48,49]. The mesolimbic dopamine pathway terminates predomi-
nantly in the nucleus accumbens. With the age, α-syn-positive neurons emerge in the nucleus
accumbens in which they appear later than in the striatum. Part of the mesolimbic dopamine
pathway from the VTA/medial SNc projects to the amygdala, the hippocampus, and the lateral
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septum. In view of the fact that these projections are not so strong as the projection to the
nucleus accumbens [50], it does not seem possible that both the amygdala and the hippocam-
pus are major subcortical structures that are subjected to α-syn accumulation from the early
stage of aging. This might be explained by considering that the α-syn pathology of these struc-
tures is linked not only with the mesolimbic dopamine system, but also probably with the
development in dementia-related diseases. With respect to the human brain pathology of
dementia-related diseases, especially PDD, DLB, and part of AD, it has been documented that
LB formation is observed primarily in the hippocampus, the amygdala, and the temporal lobe
[8]. Although the Braak’s hypothesis [31] is generally adopted for pathological progression of
PD based on LB formation, only PD cases without dementia are dealt in this hypothesis. The
stage classification of PD has been extended with dementia cases included [8]. This describes
that the LB pathology originates from the olfactory bulb and spreads to the amygdala and the
temporal lobe. Furthermore, Baba et al. [51] have recently reported that PD cases with olfac-
tory dysfunctions often result in atrophy of the amygdala and then in cognitive declines.
Taken together, α-syn accumulation in the hippocampus and the amygdala develops the
pathology of PDD and DLB. Similarly, the α-syn accumulation therein is exhibited in part of
AD, leading to cognitive declines [8].
Moreover, neurons in the VTA/medial SNc provide the mesocortical dopamine pathway to
the frontal lobe [3,38,52], and, therefore, a large part of the frontal lobe is thought to receive
dopaminergic innervation in varying degree [53–55]. It has been shown in the present study
that numbers of α-syn-positive neurons are located in the anterior cingulate cortex and the
orbitofrontal cortex from the early stage of aging, and that their age-dependent increment is
seen at a similar or even higher rate than in the VTA. This suggests that the α-syn pathology of
these frontal cortical areas may be ascribable to other mechanisms (for instance, dementia-
related disease progression), as well as to the mesocortical dopamine system. At the later stage
of aging, the occurrence of α-syn-positive neurons expands to the prefrontal cortex, in particu-
lar abundance in the dorsolateral prefrontal cortex, and in area 6 of the motor cortex (i.e., the
premotor cortex and the supplementary motor area). Then, the appearance of α-syn-positive
neurons finally reaches other areas of the prefrontal cortex, such as the ventrolateral and
medial prefrontal cortices, and in area 4 of the motor cortex (i.e., the primary motor cortex).
Although all these frontal cortical areas are likely to receive dopaminergic input from the
VTA/medial SNc [53–56], it remains unclear whether the development in the α-syn pathology
may be correlated with the richness of dopaminergic innervation. There is a consensus that
the prefrontal cortical areas, including the anterior cingulate cortex and the orbitofrontal cor-
tex, are greatly involved in diverse cognitive functions [38,52,57,58]. In this context, the α-syn
pathology of the frontal lobe might affect cognitive deficits manifested not only in PD, but also
in the dementia-related diseases, such as PDD, DLB, and part of AD.
The present results indicate that the α-syn pathology expands primarily along the dopami-
nergic neuron connectivity in a topological fashion. At the early stage of aging, α-syn-positive
neurons emerge in midbrain dopamine neurons. From the SNc, the occurrence of α-syn-posi-
tive neurons proceeds to the striatum through the nigrostriatal dopamine pathway, while from
the VTA/medial SNc, it extends to the limbic structures via the mesolimbic dopamine path-
way, and to the frontal cortical areas via the mesocortical dopamine pathway. This propagation
pattern of α-syn-positive neurons seems basically compatible to the human LB pathology. In
none of the aged macaque monkeys tested in the present study, however, either LB formation
or clinical manifestation (at least PD-like motor signs) was detected. This indicates that the α-
syn pathology is not necessarily disease-specific, but is common to normal aging. It should
also be noted here that not only the propagation associated with the midbrain dopamine sys-
tems, but also the dementia-related changes probably underlie the α-syn pathology, especially
α-Syn Pathology in Aged Monkey Brain
PLOS ONE | DOI:10.1371/journal.pone.0166861 November 18, 2016 15 / 18
in the amygdala, the hippocampus, the anterior cingulate cortex, and the orbitofrontal cortex.
Overall, the aged macaques may be useful as a potential presymptomatic model for PD and,
also, for other types neuropsychiatric disorders such as PDD, DLB, and AD.
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